Pierre Fouret
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 2%
- Molecular Biology top 10%
- Surgery top 5%
- Cancer Research top 5%
- Co-authors
- Jean‐Charles SoriaE. TaranchonKen A. OlaussenMartin FilipitsAriane DunantRobert PirkerHelmut PopperÉlisabeth Brambilla
- Topics
- Lung Cancer Treatments and Mutations (11 papers)Cancer Genomics and Diagnostics (7 papers)Salivary Gland Tumors Diagnosis and Treatment (6 papers)
- Partner nations
- FranceAustriaUnited States
In The Last Decade
Pierre Fouret
47 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Pulmonary and Respiratory Medicine 1.2k
- Oncology 1.2k
- Molecular Biology 1.1k
- Surgery 624
- Cancer Research 552
Countries citing papers authored by Pierre Fouret
This map shows the geographic impact of Pierre Fouret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Fouret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Fouret more than expected).
Fields of papers citing papers by Pierre Fouret
This network shows the impact of papers produced by Pierre Fouret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Fouret. The network helps show where Pierre Fouret may publish in the future.
Co-authorship network of co-authors of Pierre Fouret
This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Fouret. A scholar is included among the top collaborators of Pierre Fouret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Fouret. Pierre Fouret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 13 | |
| 3 | 2 | |
| 4 | 17 | |
| 5 | 40 | |
| 6 | 29 | |
| 7 | 22 | |
| 8 | 47 | |
| 9 | 56 | |
| 10 | 131 | |
| 11 | 43 | |
| 12 | 54 | |
| 13 | ERCC1 as Relevant Targets in the DNA Repair Pathway | 1 |
| 14 | DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapybreakdown → | 1320 |
| 15 | 32 | |
| 16 | 74 | |
| 17 | 27 | |
| 18 | 14 | |
| 19 | 54 | |
| 20 | 1 |
About Pierre Fouret
Pierre Fouret is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 47 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Cancer Genomics and Diagnostics (7 papers) and Salivary Gland Tumors Diagnosis and Treatment (6 papers). The work is most often cited by research in Otorhinolaryngology (219 citations), Oncology (1.2k citations) and Pulmonary and Respiratory Medicine (1.2k citations). Pierre Fouret has collaborated with scholars based in France, Austria and United States. Frequent co-authors include Jean‐Charles Soria, E. Taranchon, Ken A. Olaussen, Martin Filipits, Ariane Dunant, Robert Pirker, Helmut Popper, Élisabeth Brambilla, Thierry Le Chevalier and Jean‐Pierre Pignon. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.